Sectors

VRNA
Verona Pharma plc
106.91
undefined x undefined
undefined x undefined
bid
ask
+
0.12
0.11%
04:00 PM
timesize
Ytd130.21%
1y233.99%
106.81
day range
106.93
31.09
52 week range
106.93
Open106.85Prev Close106.79Low106.81High106.93Mkt Cap72.68B
Vol0.00Avg Vol3.56MEPS-1.04P/E-102.80Forward P/E-381.82
Beta0.05Short Ratio1.56Inst. Own92.23%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg105.93200-d Avg78.661yr Est0.00

VRNA News

Oracle Corp Sees Significant Reduction in Jeremy Grantham's Portfolio
gurufocus.com
Oracle Corp Sees Significant Reduction in Jeremy Grantham's Portfolio

Insights from Jeremy Grantham (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Jeremy Grantham (

Mueller Industries Inc: A Key Focus in Mario Gabelli's Latest 13F Filing
gurufocus.com
Mueller Industries Inc: A Key Focus in Mario Gabelli's Latest 13F Filing

Insights into Mario Gabelli (Trades, Portfolio)'s Investment Moves in Q4 2025 Mario Gabelli (Trades,

benzinga.com
The Year-End 2025 Biotech Rally And What It Means For 2026

Oracle Corp Sees Significant Reduction in Jeremy Grantham's Portfolio
gurufocus.com
Oracle Corp Sees Significant Reduction in Jeremy Grantham's Portfolio

Insights from Jeremy Grantham (Trades, Portfolio)'s Third Quarter 2025 13F Filing Jeremy Grantham (T

Sumitomo Mitsui Trust Group Inc. Buys 205 Shares of Verona Pharma PLC American Depositary Share $VRNA
defenseworld.net
Sumitomo Mitsui Trust Group Inc. Buys 205 Shares of Verona Pharma PLC American Depositary Share $VRN

Sumitomo Mitsui Trust Group Inc. increased its stake in Verona Pharma PLC American Depositary Share

Verona Pharma PLC American Depositary Share (VRNA) Projected to Post Earnings on Monday
defenseworld.net
Verona Pharma PLC American Depositary Share (VRNA) Projected to Post Earnings on Monday

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA - Get Free Report) is anticipated to annou

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
globenewswire.com
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Veron

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
globenewswire.com
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA)

Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
globenewswire.com
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS Internati

Posters support Ohtuvayre ® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy
zacks.com
All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy

Verona Pharma (VRNA) might move higher on growing optimism about its earnings prospects, which is re

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today
fool.com
Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $

Investing in index funds is a safe way to grow your portfolio over the years. But there's a huge adv

Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks
zacks.com
Volatility-Proof Your Portfolio With VIPS, GDS, FUTU & VRNA Stocks

Shield your portfolio from market swings with low-beta picks like VIPS, GDS, FUTU and VRNA, each sho

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now
zacks.com
Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

In a volatile market, low-beta picks like VIPS, ALKT, FUTU and VRNA offer investors stability with s

What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?
zacks.com
What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?

Does Verona Pharma PLC American Depositary Share (VRNA) have what it takes to be a top stock pick fo

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Verona Pharma plc (NASDAQ: VRNA)
globenewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Verona Pharma plc (NASDAQ

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA
businesswire.com
VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Inv

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?
zacks.com
Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmo

Major deals involving U.S. drugmakers and biotechs over the past decade
reuters.com
Major deals involving U.S. drugmakers and biotechs over the past decade

Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's str

Merck to Buy Verona Pharma for Around $10 Billion
youtube.com
Merck to Buy Verona Pharma for Around $10 Billion

Merck agreed to buy respiratory drugmaker Verona Pharma for about $10 billion as it tries to make up

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders
businesswire.com
VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck
zacks.com
Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck

VRNA jumps 20% after Merck unveils buyout to add COPD drug Ohtuvayre and reduce its reliance on Keyt

benzinga.com
Earnings Scheduled For February 27, 2025

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday